Morgan Stanley Maintains Spire(SR.US) With Hold Rating, Maintains Target Price $75
Spire (SR) Receives a Hold From Morgan Stanley
Analysts Offer Insights on Utilities Companies: Fluence Energy (FLNC) and Spire (SR)
Spire Inc Is Maintained at Equal-Weight by Morgan Stanley
Spire Inc Is Maintained at Hold by Stifel
Morgan Stanley Maintains Spire(SR.US) With Hold Rating, Cuts Target Price to $75
Morgan Stanley Sticks to Its Hold Rating for Spire (SR)
Spire Analyst Ratings
Spire Inc Is Maintained at Equal-Weight by Wells Fargo
Wells Fargo Maintains Spire(SR.US) With Hold Rating, Maintains Target Price $75
UBS Maintains Spire(SR.US) With Buy Rating, Raises Target Price to $80
Wells Fargo Maintains Spire(SR.US) With Hold Rating, Raises Target Price to $75
Spire's Financial Outlook: Hold Recommendation Amid Execution Challenges and EPS Growth Concerns
Barclays Remains a Buy on Spire Healthcare (SPI)
RBC Capital Remains a Buy on Spire Healthcare (SPI)
Spire Inc Is Maintained at Neutral by Mizuho
Spire Analyst Ratings
Spire Global Analyst Ratings
Spire Global's Strategic Sale Enhances Financial Stability and Growth Prospects: Buy Rating Affirmed
Baird Maintains Neutral on Spire Global, Raises Price Target to $16